Wells Fargo & Company »

Oncternal Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Oncternal Therapeutics

Apr 2024May 2024Jun 2024Jul 2024Aug 2024Sep 2024Oct 202450010001500200025003000300350400
Value ($)Share countHistorical Oncternal Therapeutics position of Wells Fargo & … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $538 408 1.32
2024-06-30 $2.3k 300 7.60
2024-03-31 $2.9k 322 9.00